New York, NY, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation. (Nasdaq: NVAC) (the “Company”) announced that it has received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Form 10-Q for the period ended September 30, 2024, the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchan ...

 Millicom (Tigo) updates on Interim Dividend and intended SDR delisting from Nasdaq Stockholm Luxembourg, December 11, 2024 – Millicom International Cellular S.A. (“Millicom” or the “Company”), today announced further details regarding the payment of the Interim Dividend and the intended delisting of SDRs from Nasdaq Stockholm, including removal as from January 13, 2025 of certain fees for conversions of SDRs to Millicom U.S. Shares traded at Nasdaq U.S.. Update on dates relating to the Interim Dividend ...

KISSIMMEE, Fla., Dec. 11, 2024 (GLOBE NEWSWIRE) -- ECD Automotive Design, Inc. (Nasdaq: ECDA) (“ECA Auto Design” or the “Company”), an industry leader in delivering restored, modified and electrified Land Rover Defenders, Jaguars, Ford Mustangs, and Toyota FJs, received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the Company is delinquent in filing its Form 10-Q for the quarter ended September 30, 2024, the Company no longer complies with Nasdaq Li ...

Super Micro Computer Inc. SMCI is walking a tightrope this week, with its spot on the Nasdaq 100 Index hanging in the balance. As the index reshuffles its lineup every December, the San Jose, California-based firm finds itself on the potential chopping block, alongside other underperforming stocks like Moderna Inc MRNA and Biogen Inc BIIB.Super Micro Computer benefitted from the surging demand for artificial intelligence infrastructure. At one point, it boasted a market cap of $67 billion. But a recent audi ...

LONDON, Dec. 11, 2024 (GLOBE NEWSWIRE) -- On December 10, 2024, VivoPower International PLC (Nasdaq: VVPR) ("VivoPower" or the "Company") received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company’s common stock has maintained a minimum bid closing price of $1.00 per share or greater for 10 consecutive business days. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2). About VivoPower  Established in 2014 and liste ...

Herzliya Israel, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today announced that Sharon Carmel, Chief Executive Officer, was recently featured in the Nasdaq Amplify Issuer Spotlight interview series at the Nasdaq MarketSite. Watch the full interview with Beamr CEO Sharon Carmel on Beamr’s investor relations website here In the interview, Carmel highlighted Beamr’s latest advancements and shared the company's vision for the f ...

纳斯达克指数表现 - 纳斯达克综合指数今年已上涨32%，部分原因是市场对人工智能的热情 公司历史数据显示，纳斯达克指数在过去的年份中，如果当年涨幅超过20%，次年平均涨幅为17%；如果当年涨幅超过30%，次年平均涨幅为19% 如果今年纳斯达克指数涨幅超过30%，历史数据显示明年可能再涨19% [1][2] 亚马逊的市场地位 - 亚马逊在北美电子商务市场销售额中占据最大份额，并预计在2025年进一步扩大市场份额 美国在线销售占零售总额的比例不到17%，亚马逊在电子商务领域仍有增长空间 公司在高利润的数字广告和云计算行业也有更大的机会 [4] 亚马逊的广告业务 - 亚马逊是全球第三大广告技术公司，仅次于Alphabet的Google和Meta Platforms，并且正在迅速扩大市场份额 eMarketer预测，亚马逊的广告收入将在2025年连续第三年加速增长 公司通过在Prime Video中添加广告以及使用人工智能（如生成式AI工具）来推动广告业务增长 [5] 亚马逊的云计算业务 - 亚马逊网络服务（AWS）是基础设施和平台服务支出方面最大的公共云，市场份额为31%，几乎相当于微软和Google的总和 Jefferies的分析师Brent Thill认为，AWS在AI领域的优势在于公司可能继续使用他们熟悉的提供商来采用AI服务 AWS还在投资AI产品开发，包括定制AI芯片、Bedrock生成式AI应用和自然语言助手Amazon Q [6][7] 亚马逊的财务表现 - 亚马逊在第三季度财报中表现强劲，营收增长11%至1590亿美元，广告和云计算业务销售增长尤为强劲 运营利润率扩大了3个百分点，GAAP净收入增长52%至每股1.43美元 CEO Andy Jassy表示，AWS不仅拥有数十亿美元的AI业务，而且AI销售额正在以三位数的速度增长 [8][9] 亚马逊的长期增长潜力 - 亚马逊在电子商务、数字广告和云计算领域都有强大的存在，并且正在利用人工智能在所有三个业务领域中扩大市场份额 华尔街预计亚马逊的盈利将在明年增长25%，使得当前49倍的市盈率看起来相当合理 公司目前的市值接近2.5万亿美元，但仍有很大的增长空间 [10][11]

公司动态 - 公司于2024年12月10日宣布，董事会薪酬委员会根据纳斯达克上市规则5635(c)(4)，向16名新非执行员工授予了总计146,400股普通股的非合格股票期权奖励，作为2021年诱因激励计划的一部分[1] - 这些股票期权的行权价格为每股57.17美元，与2024年12月10日公司在纳斯达克全球精选市场的收盘价相同[2] - 股票期权将在四年内归属，其中25%在适用归属开始日期的一周年归属，其余部分在接下来的36个连续相等的月度分期归属，前提是员工在归属日期继续受雇于公司[2] 公司介绍 - 公司是一家临床阶段的制药公司，专注于内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化[3] - 公司的主要开发候选药物paltusotine是首个每日一次的口服选择性生长抑素受体类型2（SST2）非肽激动剂，目前正在临床开发中用于治疗肢端肥大症和与神经内分泌肿瘤相关的类癌综合征[3] - 公司还在开发atumelnant，一种口服的ACTH拮抗剂，目前正在完成用于治疗先天性肾上腺增生和库欣病的2期临床研究[3] - 公司的所有药物候选物都是口服给药的小分子新化学实体，源自内部药物发现工作，包括针对各种内分泌状况的额外发现项目，如甲状旁腺功能亢进、多囊肾病、Graves病（包括甲状腺眼病）、糖尿病、肥胖和GPCR靶向肿瘤学适应症[3]

文章核心观点 - 公司已重新符合纳斯达克最低股价要求，恢复合规状态 [1][2] 公司恢复合规的具体情况 - 纳斯达克工作人员确认公司普通股在过去10个连续交易日内的收盘价均达到或超过1美元，因此公司重新符合纳斯达克上市规则5550(a)(2)的最低股价要求 [2] - 公司普通股继续在纳斯达克资本市场交易，股票代码为"JFBR" [3] 公司背景及目标 - 公司致力于通过创建和收购产品，将其转化为市场领导者，挖掘未实现的巨大增长潜力 [4] - 公司管理层深入了解亚马逊FBA业务模式，计划利用人类能力和先进技术将产品提升到新的水平 [4] 投资者关系联系 - 投资者关系联系人为Michal Efraty，联系方式为michal@efraty.com [6]

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...